Page last updated: 2024-10-18

kynurenine and Cardiomegaly

kynurenine has been researched along with Cardiomegaly in 4 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.

Research Excerpts

ExcerptRelevanceReference
"Protocatechuic acid (3,4-dihydroxybenzoic acid) prevents oxidative stress, inflammation and cardiac hypertrophy."8.31Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase. ( Bai, L; Han, X; He, X; Jeon, MJ; Jeong, MH; Jeong, SM; Kee, HJ; Kee, SJ; Kim, SH; Zhou, H, 2023)
"Aberrant amino acid metabolism is implicated in cardiac hypertrophy, while the involvement of tryptophan metabolism in pathological cardiac hypertrophy remains elusive."8.31Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy. ( Cheng, J; Jiao, L; Nie, D; Song, J; Wang, CY; Wang, DW; Wang, F; Wang, Y; Wang, Z; Wen, Z; Wu, J; Yu, K; Yu, Q; Zhang, S; Zhao, C; Zhou, L, 2023)
" It was found that in a part of patients the long-term administration of antihypertensive drugs led to an increased accumulation of kynurenine as a manifestation of pyridoxal-5-phosphate deficiency."5.28Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension. ( Liepinja, DJ; Rudzite, VK; Silava, AK; Vitols, AV, 1990)
"Protocatechuic acid (3,4-dihydroxybenzoic acid) prevents oxidative stress, inflammation and cardiac hypertrophy."4.31Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase. ( Bai, L; Han, X; He, X; Jeon, MJ; Jeong, MH; Jeong, SM; Kee, HJ; Kee, SJ; Kim, SH; Zhou, H, 2023)
"Aberrant amino acid metabolism is implicated in cardiac hypertrophy, while the involvement of tryptophan metabolism in pathological cardiac hypertrophy remains elusive."4.31Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy. ( Cheng, J; Jiao, L; Nie, D; Song, J; Wang, CY; Wang, DW; Wang, F; Wang, Y; Wang, Z; Wen, Z; Wu, J; Yu, K; Yu, Q; Zhang, S; Zhao, C; Zhou, L, 2023)
" It was found that in a part of patients the long-term administration of antihypertensive drugs led to an increased accumulation of kynurenine as a manifestation of pyridoxal-5-phosphate deficiency."1.28Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension. ( Liepinja, DJ; Rudzite, VK; Silava, AK; Vitols, AV, 1990)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Bai, L1
Han, X1
Kee, HJ1
He, X1
Kim, SH1
Jeon, MJ1
Zhou, H1
Jeong, SM1
Kee, SJ1
Jeong, MH1
Wang, Y1
Song, J1
Yu, K1
Nie, D1
Zhao, C2
Jiao, L1
Wang, Z1
Zhou, L1
Wang, F1
Yu, Q1
Zhang, S1
Wen, Z1
Wu, J1
Wang, CY1
Wang, DW1
Cheng, J1
Liu, Y1
Li, S2
Gao, Z1
Tan, Q1
Li, Y1
Wang, D1
Wang, Q1
Rudzite, VK1
Vitols, AV1
Liepinja, DJ1
Silava, AK1

Other Studies

4 other studies available for kynurenine and Cardiomegaly

ArticleYear
Protocatechuic acid prevents isoproterenol-induced heart failure in mice by downregulating kynurenine-3-monooxygenase.
    Journal of cellular and molecular medicine, 2023, Volume: 27, Issue:16

    Topics: Animals; Cardiomegaly; Heart Failure; Isoproterenol; Kynurenine; Kynurenine 3-Monooxygenase; Mice; M

2023
Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2023, Volume: 80, Issue:10

    Topics: Animals; Cardiomegaly; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Mass Spectrometry;

2023
Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
    Cardiovascular toxicology, 2021, Volume: 21, Issue:8

    Topics: Adult; Aged; Animals; Cardiomegaly; Case-Control Studies; Cells, Cultured; Disease Models, Animal; F

2021
Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension.
    Cor et vasa, 1990, Volume: 32, Issue:1

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Volume; Cardiomegaly; Clonidine; Drug Therap

1990